Senate Bill 993 accomplishes the following:
1) Starting September 1st, Texas ODs will now be able to prescribe any oral medications needed to treat eye conditions. There are no restrictions on class of medication or prescription time length.
- The exception is that only a 3-day supply of Schedules 3,4, & 5 controlled substances can be prescribed, and ODs can't prescribe Schedules 1 or 2
2) The glaucoma co-management process, in place since 1999, is abolished. After September 1st, Texas ODs will be able to independently diagnose, treat and manage glaucoma. Five glaucoma situations must still be referred to an ophthalmologist:
- Juvenile glaucoma under 16 years of age
- acute angle closure glaucoma
- malignant/neovascular glaucoma
- glaucoma defined as "severe" by AAO definition
- glaucoma that is not responding to nonsurgical intervention
3) A peer review process for glaucoma standard-of-care complaints to the Texas Optometry Board (TOB) will be developed between TOB and the Texas Medical Board, and this review process expires in 6 years.
With SB 993 becoming law today, more people will have access to the critical eye care they need, and Optometry's important role as the source of primary eye care in Texas in strengthened. Without any doubt, this law will reduce preventable vision loss and blindness for the people of Texas.
The TOA could not have accomplished this without the members, donors, advocates, and staff that make our profession great and able to achieve progress as important as this. Thanks to each and every one of you for your sacrifice and your desire to help your patients and your profession.